[-] Show simple item record

dc.contributor.advisorAhsan, Humeraeng
dc.contributor.authorBahador, Farshad Michaeleng
dc.contributor.authorKim, Thomaseng
dc.contributor.corporatenameUniversity of Missouri--Columbia. School of Medicineeng
dc.contributor.meetingnameHealth Sciences Research Day (2010 : University of Missouri)eng
dc.date.issued2010eng
dc.description.abstractReversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomiting, seizure and visual loss. This neurologic syndrome was first described in 1996. Almost half of those patients had undergone bone marrow or solid organ transplant, and were under treatment with Cyclosporin or Tacrolimus. During the past decade its association with other co-morbidities including hypertensive encephalopathy, pre-eclamspisa/eclampsia, autoimmune diseases, post-streptococcal glomerulonephritis and Henoch-Schonlein has been shown.eng
dc.format.extent2 files (1 page, 1 poster)eng
dc.identifier.urihttp://hdl.handle.net/10355/9161
dc.languageEnglisheng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. Health Sciences Research Dayeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectaltered mental statuseng
dc.subjectbrain edemaeng
dc.subject.lcshSepticemiaeng
dc.subject.lcshCerebral edemaeng
dc.subject.lcshDeliriumeng
dc.titleAtypical presentation of posterior reversible encephalopathy syndrome in a patient with sepsiseng
dc.typeOthereng


Files in this item

[PDF]
[PDF]

This item appears in the following Collection(s)

[-] Show simple item record